Advanced Search
WANG Qi, YANG Xingzi, ZHANG Wei, YANG Zhijun, PAN Zhongmian, LI li. Preparing Suspension Array Diagnostic Kit of Matrix Metallo Proteases 9,Heparanase and Cathepsin L and Clinical Validating[J]. Cancer Research on Prevention and Treatment, 2013, 40(09): 877-882. DOI: 10.3971/j.issn.1000-8578.2013.09.014
Citation: WANG Qi, YANG Xingzi, ZHANG Wei, YANG Zhijun, PAN Zhongmian, LI li. Preparing Suspension Array Diagnostic Kit of Matrix Metallo Proteases 9,Heparanase and Cathepsin L and Clinical Validating[J]. Cancer Research on Prevention and Treatment, 2013, 40(09): 877-882. DOI: 10.3971/j.issn.1000-8578.2013.09.014

Preparing Suspension Array Diagnostic Kit of Matrix Metallo Proteases 9,Heparanase and Cathepsin L and Clinical Validating

More Information
  • Received Date: August 16, 2012
  • Revised Date: February 17, 2013
  • Objective To develop a rapid,high-throughput screening method of suspension array technique to simultaneously detect matrix metallo protenases 9(MMP9),heparanase(Hpa),and cathepsin L(CL) in serum,and to explore their clinical diagnosis value for ovarian cancer.Methods The suspended arrays of MMP9,Hpa and CL were prepared by adopting the fluorescent microspheres coated with antibody.Suspension array technology and enzyme-linked immunosorbent assay were performed to detect serum concentrations of MMP9,Hpa and CL in 83 patients with ovarian cancer,50 cases of benign ovarian tumor and 55 cases of healthy women.The sensitivity of two methods was analyzed.Results The dynamic range of suspension array was 7~2 056 u/ml,coefficient of variation was 3.39%~6.15%.The corresponding linear range of enzyme-linked immunosorbent assay was 20~1 024 u/ml,coefficient of variation range was 6.45%~11.82%.The sensitivity and specificity of MMP9,Hpa and CL combined detection by suspension array were 90.4% and 92.0% respectively in diagnosis of ovarian cancer. Similarly the sensitivity and specificity were 91.1%,92.6% in diagnosis of ovarian cancer before surgery. Conclusion Suspension array of MMP9,Hpa and CL has higher sensitivity and wider dynamic range than ELISA method in detecting serum protein,and is a high-throughput,multi-factor quantitative rapid detection for ovarian cancer.
  • [1]
    Shaaban A,Rezvani M.Ovarian cancer:detection and radiologic staging[J].Clin Obstet Gynecol,2009,52(1):73-93.
    [2]
    Shield K,Ackland ML,Ahmed N, et al. Multicellular spheroids in ovarian cancer metastases:biology and pathology[J].Gynecol Oncol,2009,113(1):143-8.
    [3]
    Nolan JP,Sklar LA.Suspension array technology:evolution of the flat-array paradigm[J].Trends Biotechnol,2002,20(1):9-12.
    [4]
    de Jager W,Prakken BJ,Bijlsma JW, et al. Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies[J].J Immunol Methods,2005,300(1-2):124-35.
    [5]
    Chen YS.The clinical utility of rumor biomarkers[J].Zhonghua Jian Yan Yi Xue Za Zhi,2000,23(1):52-5.[陈允硕.肿瘤标志物的临床应用价值[J].中华检验医学杂志,2000,23(1):52-5.]
    [6]
    Kayaba H.Tumor markers:essential diagnostic tools for radiologists[J].Nihon Igaku Hoshasen Gakkai Zasshi,2003,63(4):133-9.
    [7]
    Kong XT.Application and evaluation of tumor biomarkers[J].Shi Yong Zhong Liu Za Zhi,2002,17(5):289-92.[孔宪涛.肿瘤标志物应用进展与评价[J].实用肿瘤杂志,2002,17(5):289-92.]
    [8]
    Alley WR Jr,Madera M,Mechref Y, et al. Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans:a potential methodology for cancer-biomarker discovery[J].Anal Chem,2010,82(12):5095-106.
    [9]
    Zhang A,Meng L,Wang Q, et al. Enhanced in vitro invasiveness of ovarian cancer cells through up-regulation of VEGF and induction of MMP-2[J].Oncol Rep,2006,15(4):831-6.
    [10]
    Sakata K,Shigemasa K,Nagai N, et al. Expression of matrix metalloproteinases (MMP-2,MMP-9,MT1-MMP) and their inhibitors (TIMP-1,TIMP-2) in common epithelial tumors of the ovary[J].Int J Oncol,2000,17(4):673-81.
    [11]
    Hu XX,Li L,LI DR, et al. Inhibitory effects of antisense MMP-9 oligodeoxy nucleotides on invasiveness and adherence of ovarian cancer cells[J].Zhonghua Zhong Liu Za Zhi,2006,28(9):662-5.[胡晓霞,李力,黎丹戎,等.基质金属蛋白酶-9反义寡核苷酸对卵巢癌细胞侵袭黏附能力的影响[J].中华肿瘤杂志,2006,28(9):662-5.]
    [12]
    Karihtala P,Menp J,Turpeenniemi-Hujanen T, et al. Front-line bevacizumab in serous epithelial ovarian cancer:biomarker analysis of the FINAVAST trial[J].Anticancer Res,2010,30(3):1001-6.
    [13]
    Krueger S,Kellner U,Buehling F, et al. Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line:effects on the invasive phenotype[J].Cancer Gene Ther,2001,8(7):522-8.
    [14]
    Levicar N,Dewey RA,Daley E, et al. Selective suppression of cathepsin L by antisense cDNA impairs human brain tumor cell invasion in vitro and promotes apoptosis[J].Cancer Gene Ther,2003,10(2):141-51.
    [15]
    Shinyo Y,Kodama J,Hongo A, et al. Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer[J].Ann Oncol,2003,14(10):1505-10.
    [16]
    Mao J,Xin XY,Liu Y, et al. Correlation of expression of heparanase and uPA to invasion of ovarian cancer[J].Xian Dai Zhong Liu Yi Xue,2006,14(3):329-31.[毛敬,辛晓燕,刘玉,等.卵巢癌uPA及HPA的表达与肿瘤转移的相关性研究[J].现代肿瘤医学,2006,14(3):329-31.]
    [17]
    Epelman M,Chikwava KR,Chauvin N, et al. Imaging of pediatric ovarian neoplasms[J].Pediatr Radiol,2011,41(9):1085-99.
  • Related Articles

    [1]XIA Lin, YU Guozheng, TANG Jing. Diagnostic Value of Circular RNAs for Colorectal Cancer: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2021, 48(9): 864-870. DOI: 10.3971/j.issn.1000-8578.2021.21.0069
    [2]LIANG Tong, LIU Huajie, DA Mingxu. Metabolic Syndrome and Risk of Gastric Cancer: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2021, 48(3): 268-273. DOI: 10.3971/j.issn.1000-8578.2021.20.0957
    [3]JIAN Yaowen, WANG Lei, Liu Ye, HE Mingyan, RANG Weiqing. A Meta-analysis of Dietary Vitamin Consumption and Risk of Hepatocellular Carcinoma[J]. Cancer Research on Prevention and Treatment, 2020, 47(2): 108-111. DOI: 10.3971/j.issn.1000-8578.2020.19.0007
    [4]ZHAO Rongchang, YU Wenyan, FENG Yuxin, ZHANG Wanli, ZHU Chunrong. Comparison of Efficacy Between S-1 and Capecitabine/Fluorouracil on Advanced Colorectal Cancer: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2019, 46(12): 1123-1130. DOI: 10.3971/j.issn.1000-8578.2019.19.0138
    [5]RAO Xionghui, LUO Hongliang, HUANG Jun, ZHU Zhengming. Prognostic and Clinicopathological Significance of PD-L1 Expression for Colorectal Cancer: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2019, 46(11): 1013-1021. DOI: 10.3971/j.issn.1000-8578.2019.19.0363
    [6]JIAN Yaowen, XIONG Wenjing, LIU Ye, LIU Yang, YANG Huixian, RANG Weiqing. A Meta-analysis on Relationship of Dietary Factors with Liver Cancer in Chinese Population[J]. Cancer Research on Prevention and Treatment, 2017, 44(7): 493-500. DOI: 10.3971/j.issn.1000-8578.2017.16.1465
    [7]YU Huihui, WEI Lixuan, LIU Yunyong, XING Xiaojing. Meta-analysis of Relationship Between Blood 25-hydroxyvitamin D Level and Colorectal Cancer[J]. Cancer Research on Prevention and Treatment, 2015, 42(04): 394-398. DOI: 10.3971/j.issn.1000-8578.2015.04.017
    [8]LIU Min, SONG Yang, YANG Fuguo. Effect of Food Intake on Risk of Rectal Cancer: A Meta-analysis[J]. Cancer Research on Prevention and Treatment, 2014, 41(12): 1343-1347. DOI: 10.3971/j.issn.1000-8578.2014.12.020
    [9]Yao Zhiwen, Zhao Zhenlong, Jiang Yumei, Mi Ying, Gu Miaoning. Meta-analysis for Association between Polymorphism of COX-2 -1195G>A and Colorectal Cancer Susceptibility[J]. Cancer Research on Prevention and Treatment, 2012, 39(02): 213-217. DOI: 10.3971/j.issn.1000-8578.2012.02.024
    [10]QIU Yue-feng, CAI Lin. Meta-analysis on Relationship between Body Mass Index and Lung Cancer Risk[J]. Cancer Research on Prevention and Treatment, 2010, 37(02): 218-222. DOI: 10.3971/j.issn.1000-8578.2010.02.025

Catalog

    Article views (1388) PDF downloads (362) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return